APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 50 filers reported holding APREA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $477,000 | – | 13,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,147,000 | 2.04% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $205,000 | 0.33% |
| Quantamental Technologies LLC | 13,752 | $67,000 | 0.06% |
| Redmile Group, LLC | 694,918 | $3,391,000 | 0.05% |
| PDT Partners, LLC | 124,234 | $606,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 353,926 | $1,727,000 | 0.04% |
| Virtu Financial LLC | 41,142 | $201,000 | 0.02% |
| Walleye Capital LLC | 98,931 | $483,000 | 0.02% |
| SG Americas Securities, LLC | 598,395 | $2,920,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 156,678 | $765,000 | 0.01% |